Mangrove Partners IM LLC Makes New Investment in Chemed Corporation $CHE

Posted by Geri Gentry on Jun 17th, 2026

Mangrove Partners IM LLC acquired a new position in Chemed Corporation (NYSE:CHE – Free Report) in the 4th quarter, Holdings Channel.com reports. The firm acquired 1,358 shares of the company’s stock, valued at approximately $581,000.

Several other large investors have also recently bought and sold shares of the business. Commonwealth Equity Services LLC raised its position in Chemed by 3.1% in the fourth quarter. Commonwealth Equity Services LLC now owns 734 shares of the company’s stock worth $314,000 after acquiring an additional 22 shares in the last quarter. Cim LLC raised its position in Chemed by 1.1% in the third quarter. Cim LLC now owns 2,139 shares of the company’s stock worth $958,000 after acquiring an additional 24 shares in the last quarter. Smartleaf Asset Management LLC raised its position in Chemed by 71.4% in the third quarter. Smartleaf Asset Management LLC now owns 60 shares of the company’s stock worth $27,000 after acquiring an additional 25 shares in the last quarter. Eukles Asset Management raised its position in Chemed by 0.4% in the fourth quarter. Eukles Asset Management now owns 6,056 shares of the company’s stock worth $2,591,000 after acquiring an additional 25 shares in the last quarter. Finally, Merit Financial Group LLC raised its position in Chemed by 4.0% in the third quarter. Merit Financial Group LLC now owns 940 shares of the company’s stock worth $421,000 after acquiring an additional 36 shares in the last quarter. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on CHE. Zacks Research upgraded Chemed from a “strong sell” rating to a “hold” rating in a research report on Monday, April 27th. Wall Street Zen lowered Chemed from a “buy” rating to a “hold” rating in a report on Monday, June 8th. Weiss Ratings raised Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, April 29th. Royal Bank Of Canada upped their target price on Chemed from $422.00 to $436.00 and gave the company a “sector perform” rating in a report on Monday, April 27th. Finally, Oppenheimer lowered their target price on Chemed from $580.00 to $500.00 and set an “outperform” rating on the stock in a report on Friday, February 27th. Two analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $501.50.

Read Our Latest Stock Analysis on Chemed

Chemed Stock Up 2.2%

Shares of NYSE:CHE opened at $432.70 on Wednesday. The stock’s 50-day moving average price is $417.17 and its two-hundred day moving average price is $424.24. The company has a current ratio of 0.85, a quick ratio of 0.83 and a debt-to-equity ratio of 0.11. Chemed Corporation has a 12-month low of $365.20 and a 12-month high of $562.77. The firm has a market cap of $5.74 billion, a price-to-earnings ratio of 23.58, a PEG ratio of 1.59 and a beta of 0.54.

Chemed (NYSE:CHE – Get Free Report) last released its quarterly earnings data on Thursday, April 23rd. The company reported $5.65 EPS for the quarter, topping analysts’ consensus estimates of $5.30 by $0.35. The company had revenue of $657.51 million for the quarter, compared to the consensus estimate of $659.22 million. Chemed had a return on equity of 27.18% and a net margin of 10.23%.The company’s quarterly revenue was up 1.6% compared to the same quarter last year. During the same period last year, the business posted $5.63 EPS. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. On average, research analysts forecast that Chemed Corporation will post 22.3 EPS for the current year.

Chemed Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 16th. Shareholders of record on Thursday, May 28th were issued a dividend of $0.60 per share. The ex-dividend date was Thursday, May 28th. This represents a $2.40 annualized dividend and a yield of 0.6%. Chemed’s payout ratio is currently 13.08%.

Insider Activity at Chemed

In other news, Director Andrea R. Lindell sold 1,347 shares of Chemed stock in a transaction that occurred on Tuesday, June 9th. The stock was sold at an average price of $447.33, for a total value of $602,553.51. Following the completion of the transaction, the director owned 4,578 shares in the company, valued at approximately $2,047,876.74. This trade represents a 22.73% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction that occurred on Friday, May 1st. The stock was sold at an average price of $421.13, for a total value of $842,260.00. Following the completion of the transaction, the chief executive officer owned 90,219 shares of the company’s stock, valued at approximately $37,993,927.47. The trade was a 2.17% decrease in their position. The SEC filing for this sale provides additional information. 3.33% of the stock is currently owned by company insiders.

Chemed Profile

(Free Report)

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.